TODAY : Saturday, 06 September 2025
Code
PEHA
Title
PT. Phapros Tbk
Address
Head Office:
Address:Menara Rajawali Lantai 17, Jl. DR. Ide Anak Agung Gde Agung Lot#5.1
Kawasan Mega Kuningan Jakarta Selatan 12950
Phone:(021) 576 2709
Fax:(021) 576 3910
E-mail:corporate@phapros.co.id
Website:www.phapros.co.id
Branch:
Semarang 50148
Phone:(024) 7663 0021
Fax:(024) 760 5133
E-mail:factory@phapros.co.id
Website:www.phapros.co.id
Background

PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Business cp product

The company is engaged in pharmaceuticals, health care industry and non-electromedical medical devices.
Subsidiary affiliation
Commissioners
President Commissioner: Maxi Rein Rondonuwu
Commissioner: Masrizal Achmad Syarief
Independent Commissioner: Chrisma Aryani Albandjar
Independent Commissioner: Bimo Wijayanto
Per Jun 19, 2024
Directors
Director: Ida Rahmi Kurniasih
Director: Yudhi Rangkuti
Director: Maraja Jeson Siregar
Per Jun 19, 2024
Underwriter
PT. Bahana Sekuritas
Share registrar
PT bsr Indonesia
Share holders
ShareholdersShares%
PT Kimia Farma Tbk47690186056.77
Masrizal A Syarief8618935010.26
Public27690879032.97
As of Jul 01, 2024
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp 119826-Dec-2018100287625690287625690

Founders Shares26-Dec-2018100552374310840000000
Other infos

Created date
2024-03-19 11:49:02
Revised date
2024-07-01 12:33:08
Finance
 
PT. Phapros Tbk
 
2025, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016,
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year